Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3218001 | Journal of Investigative Dermatology | 2008 | 4 Pages |
Abstract
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disorder that affects approximately 15% of children in the United States. A complex disorder, AD is characterized by both skin barrier impairment and immunologic abnormalities, including decreased innate immune function and a polarized adaptive immune response. Mouse models have demonstrated the complex interdependence of immune cell–keratinocyte interactions and teased apart gene–environment relationships in a controlled setting. In this issue, Nagelkerken et al. present a mouse model with transgenic expression of apolipoprotein C1 that disrupts the skin lipid barrier and manifests many hallmark features of AD.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Tiffany C. Scharschmidt, Julia A. Segre,